https://www.selleckchem.com/pr....oducts/tiplaxtinin-p
4% (3,053) during surgeon low-volume days; 175 patients in the high-volume group and 73 patients in the low-volume group (1.7% each) achieved visual acuity worse than 3/60. There were comparable posterior capsular rupture rates (423, 1.78%) during high- and low- volume months and 21 cases (0.09%) of postoperative endophthalmitis were noted. CONCLUSIONS MSICS can be used to tackle large cataract backlogs in developing countries as good visual outcomes can be achieved in high-volume settings if standard protocols for quality c